https://www.selleckchem.com/products/ipa-3.html
Drug-resistant tuberculosis remains a major public health threat complicating tuberculosis control programs globally. Data on rifampicin resistance (RR), which is a surrogate marker for multidrug resistance, are limited among Ethiopian tuberculosis patients. This study aimed to determine the magnitude of rifampicin-resistant (RR-MT among presumptive tuberculosis patients attending St. Peter Tuberculosis Specialized Hospital, Addis Ababa, Ethiopia. A retrospective cross-sectional study was conducted at St. Peter Tuberculosis Specialized
Like
Comment
Share
